Patient selection for corneal collagen cross-linking: An updated review

Virgilio Galvis, Alejandro Tello, Alvaro I. Ortiz, Luis C. Escaf

Producción científica: Artículos / NotasArticulo en revista no especializadarevisión exhaustiva

28 Citas (Scopus)


Corneal cross-linking (CXL) is an option that in the last decade has demonstrated its efficacy and safety in halting the progression of keratoconus (KCN) and other corneal ectasias. Its indication has been extended beyond the classic definition that required evidence of KCN progression, especially in the presence of some risk factors for a possible progression (particularly the younger age). However, the results can be still somewhat variable today. There are several protocols, each with its own advantages and disadvantages. Some predictors of CXL outcome have been identified. We will review the current knowledge on patient selection for CXL, its indications, and options in special cases (such as thin corneas).

Idioma originalInglés
Páginas (desde-hasta)657-668
Número de páginas12
PublicaciónClinical Ophthalmology
EstadoPublicada - 7 abr. 2017


Profundice en los temas de investigación de 'Patient selection for corneal collagen cross-linking: An updated review'. En conjunto forman una huella única.

Citar esto